Morgan Stanley
BOLD

Morgan Stanley’s Boundless Bio BOLD Stock Holding History

Morgan Stanley’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.3K Hold
13,000
– – ﹤0.01% 6843
2025
Q4 		$15.6K Sell
13,000
-2,501
-16% -$3.12K ﹤0.01% 6774
2025
Q3 		$19.1K Sell
15,501
-1,238
-7% -$1.43K ﹤0.01% 6702
2025
Q2 		$16.9K Sell
16,739
-19,367
-54% -$25.7K ﹤0.01% 6700
2025
Q1 		$54.5K Sell
36,106
-12,550
-26% -$26K ﹤0.01% 6245
2024
Q4 		$141K Buy
48,656
+18,715
+63% +$54.5K ﹤0.01% 5921
2024
Q3 		$104K Sell
29,941
-156,991
-84% -$569K ﹤0.01% 5994
2024
Q2 		$723K Buy
+186,932
New +$1.79M ﹤0.01% 5133

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Morgan Stanley's BOLD Position: Q1 2026 in Review

Morgan Stanley held its Boundless Bio (BOLD) position steady in Q1 2026 at 13,000 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6843.

Morgan Stanley first reported a position in BOLD in Q2 2024 and has held it in 8 quarters since. The position peaked at $723K in Q2 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • Morgan Stanley held 13,000 shares of Boundless Bio worth $14.3K as of Q1 2026.
  • Morgan Stanley left its Boundless Bio share count unchanged in Q1 2026.
  • Boundless Bio made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6843 holding.
  • Morgan Stanley first reported a position in Boundless Bio in Q2 2024 and has held it in 8 quarters since.
  • Morgan Stanley's Boundless Bio position peaked at $723K in Q2 2024.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.